Document is current
Any future updates will be listed below
-
Authors
Jelovac, Ana https://orcid.org/0000-0002-7653-8531
McLoughlin, Declan M. https://orcid.org/0000-0003-4574-2799
- License Information
-
More Information
Article History
Received: 5 November 2024
Revised: 24 September 2025
Accepted: 23 October 2025
First Online: 8 November 2025
Competing interests
: DMM has received speaker’s honoraria from MECTA, Otsuka, and Janssen and an honorarium from Janssen for participating in an esketamine advisory board meeting. AJ has no competing interests to declare.
: Ethical approval was not sought or required as the study was based on previously reported data.
